Sherbrooke Park Advisers LLC Repligen Corp Transaction History

Sherbrooke Park Advisers LLC

  • $436 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$120.0 - $182.95 $1.69 Million - $2.58 Million
14,114 New
14,114 $1.78 Billion
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $442,943 - $576,992
3,200 New
3,200 $453 Million
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $211,145 - $286,728
1,300 New
1,300 $220 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.94B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email